Skip to main content

Berta Ferrer Fábrega

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Berta Ferrer Fábrega

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Projects

Vías de diseminación metastásica en distintos subtipos del melanoma maligno: Nuevos biomarcadores tumorales y dianas terapéuticas.

IP: Juan Angel Recio Conde
Collaborators: Vicente García-Patos Briones, Berta Ferrer Fábrega
Funding agency: Asociación Española Contra el Cáncer
Funding: 212500
Reference: 2015/AECC-GCE/RECIO
Duration: 01/07/2015 - 31/12/2020

Estudio de las configuraciones metabólicas inducidas por oncogenes en melanoma maligno con fines terapéuticos

IP: Juan Angel Recio Conde
Collaborators: Berta Ferrer Fábrega, Eva Muñoz Couselo
Funding agency: Instituto de Salud Carlos III
Funding: 207515
Reference: PI14/00475
Duration: 01/01/2015 - 30/06/2018

Grup de Recerca Multidisciplinar en Melanoma (GRC)

IP: Juan Angel Recio Conde
Collaborators: Vicente García-Patos Briones, Berta Ferrer Fábrega, Eva Muñoz Couselo
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014SGR1405
Duration: 01/01/2014 - 31/12/2016

Proteinas TIF1 y dermatomiositis paraneoplásicas

IP: Ernesto Trallero Araguas
Collaborators: Vicente García-Patos Briones, Berta Ferrer Fábrega, Albert Selva O'Callaghan, Gloria Aparicio Español
Funding agency: Instituto de Salud Carlos III
Funding: 121000
Reference: PI12/01320
Duration: 01/01/2013 - 31/12/2016

Related news

The findings pave the way for the development of new therapeutic strategies combining immunotherapy with p38α protein inhibitors.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study reveals that if the exposure of newborns to solar radiation of sufficient intensity to provoke a skin reaction is simultaneous with the activation of the BRAFv600E gene, it can trigger an uncontrolled proliferation of cancer cells.

Related professionals

Marta Rosal Fontana

Marta Rosal Fontana

Coordinador/a
Preclinical Core Facilities
External Strategy Directorate
Read more
Susana Anton Calvo

Susana Anton Calvo

Administration and Management
Liver Diseases
Read more
Eulàlia Miquel Serra

Eulàlia Miquel Serra

Postdoctoral researcher
Transfusional Medicine
Read more
Josep Sanjose Puig

Josep Sanjose Puig

Tècnic de recerca
Commercial and Academic Clinical Research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.